Improving the coverage of hepatitis B vaccination and active antiviral treatment for children and adolescents, monitoring the level of hepatitis B antibodies, and striving to reduce the occurrence of horizontal transmission is necessary. This evidence concerns the gene PPIB and hepatitis A virus infection.